Better Reddit Stock: Ocugen vs. Zomedica

06:04am, Saturday, 06'th Mar 2021
Both are highfliers with intriguing potential.
The prevailing logic as I see it is that the rising tide of the pet industry is going to float all boats, including ZOM stock. But the facts simply don't bear this out over the long term.
As Zomedica prepares to launch Truforma, its first commercial product, ZOM stock continues to experience volatility. The post Zomedica Stock Volatility Continues as Truforma Launch Nears appeared firs
There are heavy expectations for ZOM stock, even though Zomedica still has no revenues and a measured plan to roll out its Truforma device. The post It May Be Too Early to Believe in Zomedica Stock ap
Zomedica is a winner with its pet lab product and cash balance. ZOM stock is worth as much as $3.61 following its Truforma product launch.
ZOM stock has been on a tear this year, and is nearing the buy zone with the impending release of its Truforma Platform The post Zomedica Continues to Fly High With Its Recent Positive Developments ap
ZOM Stock has risen by more than 1,000% in the last three months as the launch of Truforma looms. However, Zomedica investors may in for a shocker.
Zomedica (ZOM) stock is gaining on Monday following the release of its results for the full year of 2020 and approaching product launch. The post ZOM Stock: Why Zomedica Shares Are Zooming Higher Mond

Don't Get Suckered into the Zomedica Trade

10:18am, Monday, 01'st Mar 2021
On paper, the narrative for ZOM stock is exciting because of the relevant pet care business. However, you should analyze its true fundamentals very carefully.
ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products fo
In the meantime, the company still needs to execute the commercialization of Truforma. If it experiences any hiccups along the way, shares could fall back to lower price levels.
Long-term, ZOM stock has plenty to look forward to, including the release of its diagnostics platform. But that doesn't mean it's infallible.
Zomedica just raised approximately $200 million from a bought deal. Loaded with cash, ZOM stock look ready to move higher.
ZOM stock appears to be a trader's best friend right now, but is this stock truly a viable long-term investment opportunity? The post Zomedica Stock Has Soared 880% This Year — Here's Why appeared f

Better Buy: Ocugen vs. Zomedica

06:15am, Thursday, 18'th Feb 2021
Will these high-flyers continue to soar?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE